Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes | Zendy

Pierluigi Tricoci | Zendy; Zhen Huang | Zendy; Claes Held | Zendy; David J. Moliterno | Zendy; Paul W. Armstrong | Zendy; Frans Van de Werf | Zendy; Harvey D. White | Zendy; Philip E. Aylward | Zendy; Lars Wallentin | Zendy; Edmond Chen | Zendy; Yuliya Lokhnygina | Zendy; Jinglan Pei | Zendy; Sergio Leonardi | Zendy; Tyrus Rorick | Zendy; A. Kilian | Zendy; Lisa Jennings | Zendy; Giuseppe Ambrosio | Zendy; Christoph Bode | Zendy; Ángel Cequier | Zendy; Jan H. Cornel | Zendy; Rafael Díaz | Zendy; Aycan Fahri Erkan | Zendy; Kurt Huber | Zendy; Michael Hudson | Zendy; Lixin Jiang | Zendy; J. Wouter Jukema | Zendy; Basil S. Lewis | Zendy; A. Michael Lincoff | Zendy; Gilles Montalescot | Zendy; José Carlos Nicolau | Zendy; Hisao Ogawa | Zendy; Matthias Pfisterer | Zendy; Juan Carlos Prieto | Zendy; Witold Rużyłło | Zendy; Peter Sinnaeve | Zendy; Robert F. Storey | Zendy; Marco Valgimigli | Zendy; David J. Whellan | Zendy; Petr Widimský | Zendy; John Strony | Zendy; Robert A. Harrington | Zendy; Kenneth W. Mahaffey | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

Author(s) -

Pierluigi Tricoci,

Zhen Huang,

Claes Held,

David J. Moliterno,

Paul W. Armstrong,

Frans Van de Werf,

Harvey D. White,

Philip E. Aylward,

Lars Wallentin,

Edmond Chen,

Yuliya Lokhnygina,

Jinglan Pei,

Sergio Leonardi,

Tyrus Rorick,

A. Kilian,

Lisa Jennings,

Giuseppe Ambrosio,

Christoph Bode,

Ángel Cequier,

Jan H. Cornel,

Rafael Díaz,

Aycan Fahri Erkan,

Kurt Huber,

Michael Hudson,

Lixin Jiang,

J. Wouter Jukema,

Basil S. Lewis,

A. Michael Lincoff,

Gilles Montalescot,

José Carlos Nicolau,

Hisao Ogawa,

Matthias Pfisterer,

Juan Carlos Prieto,

Witold Rużyłło,

Peter Sinnaeve,

Robert F. Storey,

Marco Valgimigli,

David J. Whellan,

Petr Widimský,

John Strony,

Robert A. Harrington,

Kenneth W. Mahaffey

Publication year - 2011

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1109719

Subject(s) - medicine , thrombin , antagonist , receptor antagonist , pharmacology , thrombin receptor , receptor , platelet activation , platelet

Vorapaxar is a new oral protease-activated-receptor 1 (PAR-1) antagonist that inhibits thrombin-induced platelet activation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore